Philip Bidwell

Dr. Philip Bidwell

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
KHKobra Haghighi
Kobra Haghighi
PBPhilip Bidwell
Philip Bidwell
EKEvangelia G. Kranias
Evangelia G. Kranias

15 February 2014 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
JRJack Rubinstein
Jack Rubinstein
VLValerie M. Lasko
Valerie M. Lasko
SKSheryl E. Koch
Sheryl E. Koch
VSVivek P. Singh
Vivek P. Singh
VCVinicius Carreira
Vinicius Carreira
JLJohn N. Lorenz
John N. Lorenz
Transient receptor potential cation channels have been implicated in the regulation of cardiovascular function, but only recently has our laboratory described the vanilloid-2 subtype (TRPV2) in the cardiomyocyte, though its exact mechanism of action has not yet been established. This study tests the hypothesis that TRPV2 plays an important role in regulating myocyte contractility under physiological conditions. Therefore, we measured cardiac and vascular function in wild-type and TRPV2−/− mice in vitro and in vivo and found that TRPV2 deletion resulted in a decrease in basal systolic and diastolic function without affecting loading conditions or vascular tone. TRPV2 stimulation with probenecid, a relatively selective TRPV2 agonist, caused an increase in both inotropy and lusitropy in wild-type mice that was blunted in TRPV2−/− mice. We examined the mechanism of TRPV2 inotropy/lusitropy in isolated myocytes and found that it modulates Ca2+ transients and sarcoplasmic reticulum Ca2+ loading. We show that the activity of this channel is necessary for normal cardiac function and that there is increased contractility in response to agonism of TRPV2 with probenecid.

1 October 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PBPhilip Bidwell
Philip Bidwell
DBDaniel J. Blackwell
Daniel J. Blackwell
ZHZhanjia Hou
Zhanjia Hou
AZAleksey V. Zima
Aleksey V. Zima
SRSeth L. Robia
Seth L. Robia
To investigate the mechanism of regulation of sarco-endoplasmic reticulum Ca(2+)-ATPase (SERCA) by phospholamban (PLB), we expressed Cerulean-SERCA and yellow fluorescent protein (YFP)-PLB in adult rabbit ventricular myocytes using adenovirus vectors. SERCA and PLB were localized in the sarcoplasmic reticulum and were mobile over multiple sarcomeres on a timescale of tens of seconds. We also observed robust fluorescence resonance energy transfer (FRET) from Cerulean-SERCA to YFP-PLB. Electrical pacing of cardiac myocytes elicited cytoplasmic Ca(2+) elevations, but these increases in Ca(2+) produced only modest changes in SERCA-PLB FRET. The data suggest that the regulatory complex is not disrupted by elevations of cytosolic calcium during cardiac contraction (systole). This conclusion was also supported by parallel experiments in heterologous cells, which showed that FRET was reduced but not abolished by calcium. Thapsigargin also elicited a small decrease in PLB-SERCA binding affinity. We propose that PLB is not displaced from SERCA by high calcium during systole, and relief of functional inhibition does not require dissociation of the regulatory complex. The observed modest reduction in the affinity of the PLB-SERCA complex with Ca(2+) or thapsigargin suggests that the binding interface is altered by SERCA conformational changes. The results are consistent with multiple modes of PLB binding or alternative binding sites.

7 August 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
APAdam J. Pollak
Adam J. Pollak
KHKobra Haghighi
Kobra Haghighi
SKSwati Kunduri
Swati Kunduri
Demetrios ArvanitisDemetrios Arvanitis
Demetrios Arvanitis
PBPhilip Bidwell
Philip Bidwell
EKEvangelia G. Kranias
Evangelia G. Kranias
Significance: A common variant of histidine-rich Ca-binding protein (HRC), where an alanine replaces a serine at amino acid 96, can increase the risk of dying from severe heart disease. Using human, mice, and cellular models, we show that this variant blocks position 96 from becoming phosphorylated, a prevalent type of protein modification carried out by kinase enzymes. We demonstrate that phosphorylation of HRC at Ser96 indeed provides protection from heart disease, and we identify family with sequence similarity 20C (Fam20C) as the kinase that phosphorylates HRC. HRC phosphorylation appears to play a role in regulating Ca cycling that is critical for proper cardiac muscle contraction. This demonstration of Fam20C’s role in heart disease opens up avenues for potential preventative or therapeutic strategies.

1 January 2007 in Experimental Cell Research
Verified
Journal Article
Closed access
SRStephen Rush
Stephen Rush
GKGausal Khan
Gausal Khan
ABAyoola Bamisaiye
Ayoola Bamisaiye
PBPhilip Bidwell
Philip Bidwell
HLH. Anne Leaver
H. Anne Leaver
MRMaria Teresa Rizzo
Maria Teresa Rizzo

1 January 2020 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
DSDaniel R. Stroik
Daniel R. Stroik
DCDelaine K. Ceholski
Delaine K. Ceholski
PBPhilip Bidwell
Philip Bidwell
JMJustyna Mleczko
Justyna Mleczko
PTPaul F. Thanel
Paul F. Thanel
DTDavid Thomas
David Thomas